HST Global Announces New Scientific Board Member

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB: HSTC), an integrated biotechnology and wellness company, today announced the appointment of Dr. Kyl Smith to its Scientific Board.

HST Global, Inc. is proud to announce the appointment of Dr. Kyl Smith to its Scientific Advisory Board. Dr. Smith has enjoyed a high position of visibility in the world of natural medicine. He is a noted researcher, inventor, lecturer, author and scientist, and is well- known as the inventor of Focus Factor^®, the number-one selling brain support product in North America for the last seven years. Dr. Kyl has appeared on hundreds of radio and television programs across the country in the last decade – he’s the author of the acclaimed Brighter Mind^® book series, and is a popular speaker providing Continuing Education programs for physicians. His passion is teaching doctors how to utilize and integrate nutritional therapies to improve cognitive function in practice based on clinical research as published in peer-reviewed literature.

Professionally, Dr. Kyl received his doctorate of Chiropractic in 1993, and has since engaged in nutrition and natural medicine research. Most notably, in 2001 – with the help of some of the top scientists in the world, including a former senior scientist for the American Medical Association – Dr. Kyl filed a Health Claim Petition for Phosphatidylserine, which was approved by the Food and Drug Administration (FDA) in 2002.

This is an unprecedented accomplishment; it represents the first Health Claim for cognitive function to be approved in the FDA’s history. As a result, Dr. Kyl received the James Lind Scientific Achievement Award, which acknowledges the accomplishments of those who have contributed to the scientific advancement of natural medicine and are helping to reshape the very structure of American health care.

Dr. Kyl is a member of the Institute for Functional Medicine; the American Botanical Council; the International Society of Regulatory Toxicology and Pharmacology; and the Vice-President of Membership for the Academy of Bio-Energetic and Integrative Medicine (A.B.E.I.M.).

Ronald Howell, President and CEO of HST Global, Inc. stated, “There is a growing acceptance of integrative wellness and cancer treatments worldwide and HST is perfectly positioned to open our own brand of Integrative Wellness and Cancer Treatment Centers. The addition of Dr. Kyl Smith to our Scientific Advisory Board will enable the company to strengthen our ability to address multiple challenges individuals face in the maintenance and treatment of numerous health conditions, and to provide Continuing Education modules and courses for physicians who wish to learn about scientifically validated integrative therapies.”

There is a growing population of individuals experiencing the lack of available alternatives in treating life threatening and debilitating diseases. Dr. Smith has been working with a number of highly visible Physicians that are developing successful application technologies that are meeting with success in the treatment and support of this population.

About HST Global, Inc.

HST Global, Inc. is a development stage biotechnology company that acquires and develops innovative products for the treatment of cancer and other life threatening illnesses. We focus on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer, then developing those drug candidates for commercial use and developing a network of Wellness Centers Worldwide.